DudeDiligence.

Liminatus Pharma, Inc

LIMNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

Shares on issue

56.0M

From 26.0M in June 2025

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

None

No at-the-market programme on file in the last 30 months.

Warrants

1

Warrants of every class, exercise price $11.50.

Cash

under 0.1 quarters

$0 cash on hand.

Raised
DateWhatSharesPriceGrossFiling
2026-11-02Private placement260,001$2.50$650K8-K ↗
2026-02-17Public offering13,813,000$0.29$4.0M424B4 ↗
2025-05-06Private placementnot available$10.00$15.0M8-K ↗

Also on file: a 1-for-50 reverse split, 2026-08-20 8-K ↗